Everything on Therapeutic Innovation

Cell therapy is expanding beyond oncology into immunology, offering functional cures for end-stage autoimmune diseases. This shift addresses a massive unmet need and creates a new growth vector for complex modalities.

Impact: The expansion of cell therapy into immunology could drive substantial revenue growth and improve patient outcomes for chronic, debilitating conditions.

— from Novartis Strategy: Pure Play Focus and AI Integration · a16z Podcast· Feb 16, 2026

Peptides are emerging as a disruptive class of therapeutics, offering non-patentable, low-cost compounds for human enhancement and inflammation reduction, challenging the traditional pharmaceutical model.

Impact: Peptides represent a new market segment focused on human enhancement and longevity, offering entrepreneurs a chance to build products that go beyond traditional disease management.

— from TrueMed: Leveraging HSA Dollars for Preventive Health · a16z Podcast· Feb 04, 2026